Evaluation of endovascular therapy of aorto-iliac lesions

Evaluation of endovascular therapy of aorto-iliac lesions - AORTIE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032151

Enrollment

250

Registered

2023-09-29

Start date

2023-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I70.2

Interventions

Group 1: Endovascular therapy of aortoiliac lesions

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients treated with abdominal aortic interventions or aortic interventions involving the iliac arteries or iliac arteries

Exclusion criteria

Exclusion criteria: Patients who were not treated aortally or aorto-iliacal

Design outcomes

Primary

Measure	Time frame
Acute intervention success, defined as <30% residual stenosis	—

Secondary

Measure	Time frame
Freedom from target lesion revascularisation (TLR) at 12, 24, 36, 38 and 60 months. Restenosis rate after 12, 24, 36, 38 and 60 months Change in Rutherford-Becker classification at 12, 24, 36, 38 and 60 months Amputation rate after 12, 24, 36, 38 and 60 months	—

Countries

Germany

Contacts

Public ContactThomas Zeller

UHZ Campus Bad Krozingen

thomas.zeller@uniklinik-freiburg.de076334020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026